3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
2
Kidney Neoplasms
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Interventions
Anastrozole
5
palbociclib
4
abemaciclib
3
Trastuzumab
3
Fulvestrant
3
ribociclib
2
pertuzumab
2
exemestane
2
Tamoxifen
2
Letrozole
2
Gonadotropin-Releasing Hormone
2
AZD9833
2
trastuzumab deruxtecan
1
taxane
1
elacestrant
1
dalpiciclib
1
STX-478
1
RAD1901
1
Metformin
1
Leflunomide
1
Imlunestrant
1
Genotype
1
Body Height
1
Blood Specimen Collection
1
Blood Pressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Diseases
×
Genotype
×
1 year
×
Clear all
NCT05006196
2026-05-20
IMOGEN
Perspectum
Active not recruiting
1,030 enrolled